G
Goro Watanabe
Publications - 8
Citations - 2161
Goro Watanabe is an academic researcher. The author has contributed to research in topics: Cholecystectomy & Hepatectomy. The author has an hindex of 6, co-authored 8 publications receiving 1913 citations.
Papers
More filters
Journal ArticleDOI
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida,Augusto Villanueva,Masahiro Kobayashi,Judit Peix,Derek Y. Chiang,Amy L. Camargo,Supriya Gupta,Jamie Moore,Matthew J. Wrobel,Jim Lerner,Michael R. Reich,Jennifer A. Chan,Jonathan N. Glickman,Kenji Ikeda,Masaji Hashimoto,Goro Watanabe,Maria Grazia Daidone,Sasan Roayaie,Myron Schwartz,Swan N. Thung,Helga B. Salvesen,Stacey Gabriel,Vincenzo Mazzaferro,Jordi Bruix,Scott L. Friedman,Hiromitsu Kumada,Josep M. Llovet,Todd R. Golub +27 more
TL;DR: The feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues is demonstrated and it is shown that a reproducible gene-expression signature correlated with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma.
Journal ArticleDOI
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Yujin Hoshida,Sebastian M.B. Nijman,Sebastian M.B. Nijman,Masahiro Kobayashi,Jennifer A. Chan,Jennifer A. Chan,Jean Philippe Brunet,Derek Y. Chiang,Augusto Villanueva,Philippa Newell,Kenji Ikeda,Masaji Hashimoto,Goro Watanabe,Stacey Gabriel,Scott L. Friedman,Hiromitsu Kumada,Josep M. Llovet,Todd R. Golub,Todd R. Golub +18 more
TL;DR: Three robust HCC subclasses are observed, each correlated with clinical parameters such as tumor size, extent of cellular differentiation, and serum alpha-fetoprotein levels, and it is indicated that S1 reflected aberrant activation of the WNT signaling pathway, S2 was characterized by proliferation as well as MYC and AKT activation, and S3 was associated with hepatocyte differentiation.
Journal ArticleDOI
Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients.
Kazunari Sasaki,Masamichi Matsuda,Yu Ohkura,Yusuke Kawamura,Masaji Hashimoto,Kenji Ikeda,Hiromitsu Kumada,Goro Watanabe +7 more
TL;DR: In patients with hepatoviral infection, although a wide resection margin can eradicate the microsatellite lesions around hepatocellular carcinoma, a large‐volume hepatectomy may diminish remaining liver function and become an obstacle for treating recurrent HCC.
Journal ArticleDOI
Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter.
Kenji Ikeda,Masahiro Kobayashi,Satoshi Saitoh,Takashi Someya,Tetsuya Hosaka,Hitomi Sezaki,Yoshiyuki Suzuki,Fumitaka Suzuki,Norio Akuta,Yasuji Arase,Hiromitsu Kumada,Masamichi Matsuda,Masaji Hashimoto,Goro Watanabe +13 more
TL;DR: Cost-effectiveness of RFA in the treatment of small HCC was superior to that of surgery, and local recurrence rates after RFA and surgery were similar.
Journal ArticleDOI
Elevation of Pancreatic Enzymes in Gallbladder Bile Associated with Heterotopic Pancreas. A Case Report and Review of the Literature
TL;DR: This is the first report associating heterotopic pancreas in the gallbladder and elevated pancreatic enzymes in bile to play an important role in the occurrence of acalculous cholecystitis and biliary cancer.